Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease)Uncontrolled Diabetes (HBA1c ≥ 10)
Interventions
OTHER

IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)

IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) is an intervention designed to be delivered in primary care settings by an on-site occupational therapist. Based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease, the 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning.

OTHER

Usual primary care services

Usual primary care services might include monitoring of vitals and other relevant laboratory testing, prescription of medications for chronic disease management, as well as counseling for lifestyle changes.

Trial Locations (1)

60608

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Illinois at Chicago

OTHER

NCT04682977 - Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline | Biotech Hunter | Biotech Hunter